What the Future Holds

+27 (0) 86 219 9157

Over 4,000 trials involving Stem Cells with over 200 of these trials using Umbilical Cord Blood Stem Cells. Clinical trials analyse new medical treatments for their safety, efficiency and potentially adverse effects in humans.

Dr. Marcin Jurga

R&D Manager, Cryo-Save

“Apart from current therapies using Haematopoietic Stem Cells, from Umbilical Cord Blood, there is an incresing number of clinical trials using Mesenchymal Stem Cells. These are used in researching a broader scope of applications, such as treatments of: Nervous system diseases, Graft-vs-Host disease, orthopedic injuries and disorders, cardiovascular illnesses, diabetic patients, but also in tissue engineering applications where entire organs can be produced. The future of Stem Cell applications is yet to show its full potential.”

Prof. Dr. Daniel Surbek

“Evidence from recent studies suggests that transplantation of Stem Cells from the Umbilical Cord may be used as treatment for severe perinatal brain damage due to preterm delivery or birth asphyxia. Transplanted Stem Cells may regenerate damaged neural tissue and central nervous system function. Several clinical trials in children affected by cerebral palsy are ongoing.”

Dr. Csaba Papp

“Together with the Umbilical Cord Blood, the preservation of the Cord Tissue is not only a possibility for obtaining mesenchymal Stem Cells, but for yielding other Cells that are important for future Stem Cell therapies.”